LncRNA MEG3 Inhibits the Epithelial-mesenchymal Transition of Bladder Cancer Cells through the Snail/E-cadherin Axis

Liang Wang1, Ping Wang2, Bing Liu3

  • 1Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

PubMed
Abstract

Insights

Maternally expressed gene 3 (MEG3) long noncoding RNA inhibits bladder cancer cell invasion and migration. MEG3 suppresses epithelial-mesenchymal transition (EMT) by targeting Snail, offering a potential therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Bladder cancer is a significant health concern.
  • Epithelial-mesenchymal transition (EMT) is a key process in cancer progression and metastasis.
  • Long noncoding RNAs (lncRNAs) are emerging as critical regulators in various cancers.

Purpose of the Study:

  • To investigate the role of maternally expressed gene 3 (MEG3) lncRNA in bladder cancer.
  • To elucidate the mechanisms by which MEG3 affects epithelial-mesenchymal transition (EMT) in bladder cancer cells.

Main Methods:

  • Assessed cell invasion, migration, and wound healing.
  • Measured E-cadherin expression via Western blotting, RT-qPCR, and dual luciferase reporter assays.
  • Investigated MEG3 interactions with downstream targets using RNA immunoprecipitation and pull-down assays.

Main Results:

  • MEG3 significantly suppressed bladder cancer cell invasion and migration.
  • MEG3 modulated E-cadherin transcription by binding to the Snail transcription factor.
  • MEG3 inhibited EMT signaling pathways (ERK, JNK, P38), reducing Snail and increasing E-cadherin expression.

Conclusions:

  • MEG3 plays a crucial role in suppressing EMT in bladder cancer.
  • MEG3 demonstrates potential as a therapeutic target for bladder cancer treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.0K